2022. Does Fidaxomicin reduce Cure and Recurrence rates compared to Vancomycin in Clostridium Difficile Infection patients?: A Systematic Review and Meta-analysis. GAIMS Journal of Medical Sciences. 2, 1 (Jan-Jun) (Jun. 2022), 30–35.